This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Bristol-Myers Squibb Compnay, Immunome, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,745 
1 out of 11 Years Active: 2025
Title: The Innovative Contributions of Matti Davis
Introduction
Matti Davis is a notable inventor based in Modiin, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Matti Davis holds a patent for bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof. This invention provides compositions that include bisfluoroalkyl-1,4-benzodiazepinone compounds, which can be used in combination with additional cancer therapeutic agents. The methods outlined in his patent aim to treat diseases and disorders such as cancer.
Career Highlights
Throughout his career, Matti has worked with prominent companies in the pharmaceutical industry, including Immunome, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Matti has collaborated with several professionals in his field, including Bruce S. Fischer and Gaurav Bajaj. These collaborations have likely enhanced his research and development efforts.
Conclusion
Matti Davis is a distinguished inventor whose work in developing bisfluoroalkyl-1,4-benzodiazepinone compounds showcases his commitment to advancing cancer treatment. His contributions to the pharmaceutical industry reflect his innovative spirit and dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile